Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
225.57
-1.93 (-0.85%)
Apr 27, 2026, 1:59 PM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14 Dec '13 Dec '12
Innovative Medicine Revenue
61.95B60.40B56.96B
Innovative Medicine Revenue Growth
2.57%6.03%4.03%
MedTech Revenue
34.41B33.79B31.86B
MedTech Revenue Growth
1.82%6.07%4.79%
Revenue (Total)
96.36B94.19B88.82B
Revenue (Total) Growth
2.30%6.05%4.30%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14 Dec '13 Dec '12
United States Revenue
54.78B53.75B50.30B
United States Revenue Growth
1.91%6.86%8.31%
Europe Revenue
22.27B21.54B20.21B
Europe Revenue Growth
3.43%6.55%-0.97%
Western Hemisphere ex-US Revenue
5.00B4.88B4.71B
Western Hemisphere ex-US Revenue Growth
2.58%3.42%3.63%
Asia Pacific, Africa Revenue
14.31B14.03B13.59B
Asia Pacific, Africa Revenue Growth
2.00%3.22%-1.19%
Revenue (Total)
96.36B94.19B88.82B
Revenue (Total) Growth
2.30%6.05%4.30%

EBT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14 Dec '13 Dec '12
Innovative Medicine Income Before Tax
22.37B22.27B18.92B
Innovative Medicine Income Before Tax Growth
0.48%17.69%3.69%
MedTech Income Before Tax
3.93B4.11B3.74B
MedTech Income Before Tax Growth
-4.42%9.97%-19.90%

Capital Expenditures

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14 Dec '13 Dec '12
Innovative Medicine Capital Expenditures
2.08B1.71B
Innovative Medicine Capital Expenditures Growth
21.40%3.45%
MedTech Capital Expenditures
2.50B2.44B
MedTech Capital Expenditures Growth
2.37%2.99%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21 Dec '19 Dec '18 Dec '17 Jan '17 Jan '16 Dec '14 Dec '13 Dec '12
Sales % Change due to Transactions
8.405.90
Sales % Change due to Transactions Growth
42.37%-13.23%
Sales % Change due to Price
-3.10-
Sales % Change due to Currency
0.70-1.60
Updated Apr 14, 2026. Data Source: Fiscal.ai.